INSULIN GLARGINE U-100 – THE UNBRANDED BIOLOGIC THAT IS IDENTICAL TO LANTUS
Winthrop US is a Sanofi company dedicated to delivering unbranded versions of Sanofi products, including this unbranded biologic for Lantus.
Insulin glargine U-100 is an unbranded biologic for Lantus, ensuring you have the same product experience as Lantus.
- Insulin Glargine U-100 uses the same manufacturing process as Lantus.
- It is identical to Lantus in molecular weight distribution, quality control parameters, and inactive ingredients.
LEARN MORE ABOUT WINTHROP
Winthrop, a Sanofi Company, is dedicated to ensuring patients get the same quality product they would from Sanofi’s brand name products. Winthrop products are identical to Sanofi products in molecular weight distribution, quality control parameters, inactive ingredients and other key factors. Quality, affordability, and service are the foundation of our relationship with patients and those that serve them.
To find out more please contact WinthropUS@sanofi.com
LANTUS and Insulin Glargine U-100 are long-acting man-made-insulins used to control high blood sugar in adults and children with diabetes mellitus. LANTUS is not for use to treat diabetic ketoacidosis
Important Safety Information
Important Safety Information for Lantus® and Insulin Glargine U-100
The Important Safety Information for Insulin Glargine U-100 is the same as for Lantus.
Do not take Lantus during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus.
Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.
Before starting Lantus, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus. Your treatment with TZDs and Lantus may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:
- Shortness of breath
- Swelling of your ankles or feet
- Sudden weight gain
Tell your doctor about all the medications you take, including over the counter medicines, vitamins, and supplements, including herbal supplements.
Lantus should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.
Do NOT dilute or mix Lantus with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.
While using Lantus, do not drive or operate heavy machinery until you know how Lantus affects you. You should not drink alcohol or use other medicines that contain alcohol.
The most common side effect of insulin, including Lantus, is low blood sugar (hypoglycemia), which may be serious and life threatening. It may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.
Lantus may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:
- A rash over your whole body
- Trouble breathing
- A fast heartbeat
- Sweating
- Swelling of your face, tongue, or throat
- Shortness of breath
- Extreme drowsiness, dizziness, or confusion
Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.
Important Safety Information for Lantus® (insulin glargine injection) SoloStar® and Insulin Glargine U-100 SoloSTAR®
Lantus SoloSTAR and Insulin Glargine U-100 SoloSTAR are disposable single-patient-use prefilled insulin pens. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.
Click here for Full Prescribing Information for Lantus.
Click here for Full Prescribing Information for Insulin Glargine U-100.
Click here for information on Sharps Medical Waste Disposal.
Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.
*Eligibility Restrictions & Offer Terms:
Insulins Valyou Savings Program:
Sanofi insulins included in this program are: ADMELOG® (insulin lispro) injection 100 Units/mL, TOUJEO® SoloStar® (insulin glargine) injection 300 Units/mL, TOUJEO® Max SoloStar (insulin glargine) injection 300 Units/mL, Insulin glargine U-300 Max SoloStar injection and Insulin glargine U-300 SoloStar injection, LANTUS® (insulin glargine) injection 100 Units/mL, and APIDRA® (insulin glulisine) injection 100 Units/mL.
Sanofi Insulins Co-pay Savings Program:
Sanofi insulins included in this program are: ADMELOG® (insulin lispro) injection 100 Units/mL, TOUJEO® (insulin glargine) injection 300 Units/mL, LANTUS® (insulin glargine) injection 100 Units/mL, and APIDRA® (insulin glulisine) injection 100 Units/mL.For a complete list of participating brands, products, and National Drug Codes (NDCs) visit https://qrfy.com/p/Sanofi_Insulins_Co-pay.
This savings program is not insurance. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only patients without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible cash paying patients will pay $35 per 30 Day Supply. To pay $35 per 30 Day Supply, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 33 mcg/mL. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Insulins Valyou Savings Program at 833-813-0190833-813-0190 (8:00 am-8:00 pm EST, Monday-Friday).
- Lantus: Pay no more than $35 for a 30-day supply. Valid up to 10 packs per fill; valid for 1 fill every 30 days.
If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-16101-800-633-1610.
The health information contained herein is provided for general education purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
Important Safety Information for Lantus® and Insulin Glargine U-100
The Important Safety Information for Insulin Glargine U-100 is the same as for Lantus.
Do not take Lantus during episodes of low blood sugar or if you are allergic to insulin or any of the inactive ingredients in Lantus.
Do not share needles, insulin pens, or syringes with others. Do NOT reuse needles.
Before starting Lantus, tell your doctor about all your medical conditions, including if you have liver or kidney problems, if you are pregnant or planning to become pregnant or if you are breast-feeding or planning to breast-feed.
Change (rotate) your injection sites within the area you chose with each dose to reduce your risk of getting pitted or thickened skin (lipodystrophy) and skin with lumps (localized cutaneous amyloidosis) at the injection sites. Do not use the same spot for each injection or inject where the skin is pitted, thickened, lumpy, tender, bruised, scaly, hard, scarred or damaged.
Heart failure can occur if you are taking insulin together with certain medicines called TZDs (thiazolidinediones), even if you have never had heart failure or other heart problems. If you already have heart failure, it may get worse while you take TZDs with Lantus. Your treatment with TZDs and Lantus may need to be changed or stopped by your doctor if you have new or worsening heart failure. Tell your doctor if you have any new or worsening symptoms of heart failure, including:
- Shortness of breath
- Swelling of your ankles or feet
- Sudden weight gain
Tell your doctor about all the medications you take, including over the counter medicines, vitamins, and supplements, including herbal supplements.
Lantus should be taken once a day at the same time every day. Test your blood sugar levels while using insulin, such as Lantus. Do not make any changes to your dose or type of insulin without talking to your healthcare provider. Any change of insulin should be made cautiously and only under medical supervision.
Do NOT dilute or mix Lantus with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus must only be used if the solution is clear and colorless with no particles visible. Always make sure you have the correct insulin before each injection.
While using Lantus, do not drive or operate heavy machinery until you know how Lantus affects you. You should not drink alcohol or use other medicines that contain alcohol.
The most common side effect of insulin, including Lantus, is low blood sugar (hypoglycemia), which may be serious and life threatening. It may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision.
Lantus may cause serious side effects that can lead to death, such as severe allergic reactions. Get medical help right away if you have:
- A rash over your whole body
- Trouble breathing
- A fast heartbeat
- Sweating
- Swelling of your face, tongue, or throat
- Shortness of breath
- Extreme drowsiness, dizziness, or confusion
Other possible side effects may include swelling, weight gain, low potassium levels, injection site reactions, including changes in fat tissue at the injection site, and allergic reactions.
Important Safety Information for Lantus® (insulin glargine injection) SoloStar® and Insulin Glargine U-100 SoloSTAR®
Lantus SoloSTAR and Insulin Glargine U-100 SoloSTAR are disposable single-patient-use prefilled insulin pens. Please talk to your healthcare provider about proper injection technique and follow instructions in the Instruction Leaflet that accompanies the pen.
Click here for Full Prescribing Information for Lantus.
Click here for Full Prescribing Information for Insulin Glargine U-100.
Click here for information on Sharps Medical Waste Disposal.
Click here to learn more about Sanofi’s commitment to fighting counterfeit drugs.
*Eligibility Restrictions & Offer Terms:
Insulins Valyou Savings Program:
Sanofi insulins included in this program are: ADMELOG® (insulin lispro) injection 100 Units/mL, TOUJEO® SoloStar® (insulin glargine) injection 300 Units/mL, TOUJEO® Max SoloStar (insulin glargine) injection 300 Units/mL, Insulin glargine U-300 Max SoloStar injection and Insulin glargine U-300 SoloStar injection, LANTUS® (insulin glargine) injection 100 Units/mL, and APIDRA® (insulin glulisine) injection 100 Units/mL.
Sanofi Insulins Co-pay Savings Program:
Sanofi insulins included in this program are: ADMELOG® (insulin lispro) injection 100 Units/mL, TOUJEO® (insulin glargine) injection 300 Units/mL, LANTUS® (insulin glargine) injection 100 Units/mL, and APIDRA® (insulin glulisine) injection 100 Units/mL.For a complete list of participating brands, products, and National Drug Codes (NDCs) visit https://qrfy.com/p/Sanofi_Insulins_Co-pay.
This savings program is not insurance. This offer is not valid for prescriptions covered by or submitted for reimbursement, in whole or in part, under Medicare, Medicaid, VA, DOD, TRICARE, similar federal or state programs, including any state pharmaceutical programs, or commercial/private insurance. Only patients without prescription medication insurance can apply for this offer. Void where prohibited by law. For the duration of the program, eligible cash paying patients will pay $35 per 30 Day Supply. To pay $35 per 30 Day Supply, you must fill all your Sanofi Insulin prescriptions at the same time, together each month. Not valid for SOLIQUA 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 33 mcg/mL. The Insulins Valyou Savings Program applies to the cost of medication. There are other relevant costs associated with overall treatment. Sanofi reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Upon registration, patients will receive all program details. For questions regarding your eligibility or benefits, or if you wish to discontinue your participation, call the Insulins Valyou Savings Program at 833-813-0190833-813-0190 (8:00 am-8:00 pm EST, Monday-Friday).
- Lantus: Pay no more than $35 for a 30-day supply. Valid up to 10 packs per fill; valid for 1 fill every 30 days.
If you are a patient experiencing problems with a Sanofi US product, please contact Sanofi US at 1-800-633-16101-800-633-1610.
The health information contained herein is provided for general education purposes only. Your healthcare professional is the single best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.
